Anika Therapeutics Company Profile (NASDAQ:ANIK)

About Anika Therapeutics

Anika Therapeutics logoAnika Therapeutics, Inc. is an orthopedic medicines company. The Company offers therapeutic pain management solutions. It is engaged in developing, manufacturing and commercializing approximately 20 products based on its hyaluronic acid (HA) technology. It orthopedic medicine portfolio consists of marketed (ORTHOVISC and MONOVISC) and pipeline (CINGAL and HYALOFAST in the United States) products to alleviate pain and restore joint function by replenishing depleted HA and aiding cartilage repair and regeneration. Its therapeutic offerings consist of products in the areas, such as Orthobiologics, Dermal, Surgical, Ophthalmic and Veterinary. It offers products made from HA based on two technologies: HYAFF, which is a solid form of HA, and ACP gel, an autocross-linked polymer of HA. Its orthobiologics products primarily consist of viscosupplementation and regenerative orthopedics products. Its viscosupplementation franchise includes ORTHOVISC, ORTHOVISC mini, MONOVISC, and CINGAL.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Health Care Supplies
  • Exchange: NASDAQ
  • Symbol: ANIK
  • CUSIP: 03525510
Key Metrics:
  • Previous Close: $48.72
  • 50 Day Moving Average: $50.34
  • 200 Day Moving Average: $47.02
  • Trailing P/E Ratio: 21.11
  • Foreward P/E Ratio: 23.82
  • P/E Growth: 1.62
  • Market Cap: $714.62M
  • Outstanding Shares: 14,777,000
  • Beta: 1.5
Additional Links:
Companies Related to Anika Therapeutics:

Analyst Ratings

Consensus Ratings for Anika Therapeutics (NASDAQ:ANIK) (?)
Ratings Breakdown: 2 Hold Ratings, 1 Buy Rating
Consensus Rating:Hold (Score: 2.33)
Consensus Price Target: $49.50 (2.36% upside)

Analysts' Ratings History for Anika Therapeutics (NASDAQ:ANIK)
DateFirmActionRatingPrice TargetDetails
4/27/2016Northland SecuritiesDowngradeOutperform -> Market PerformView Rating Details
2/26/2016Barrington ResearchBoost Price TargetOutperform$45.00 -> $49.00View Rating Details
8/27/2015First AnalysisInitiated CoverageEqual -> Equal WeightView Rating Details
11/12/2014Singular ResearchLower Price TargetBUY -> Buy$51.50 -> $45.50View Rating Details
(Data available from 8/27/2014 forward)


Earnings History for Anika Therapeutics (NASDAQ:ANIK)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/27/2016Q216$0.44$0.57$24.75 million$26.60 millionViewListenView Earnings Details
4/27/2016Q116$0.28$0.45$19.26 million$22.30 millionViewListenView Earnings Details
2/24/2016Q415$0.60$0.72$28.19 million$25.60 millionViewListenView Earnings Details
10/28/2015Q315$0.34$0.55$22.36 million$23.70 millionViewListenView Earnings Details
7/29/2015Q215$0.34$0.51$21.65 million$22.90 millionViewListenView Earnings Details
4/28/2015Q115$0.21$0.23$16.20 million$15.50 millionViewListenView Earnings Details
2/25/2015Q414$0.48$0.51$24.60 million$23.30 millionViewListenView Earnings Details
10/30/2014Q314$0.33$0.40$20.33 million$22.10 millionViewListenView Earnings Details
7/30/2014Q214$0.57$0.60$28.20 million$26.27 millionViewListenView Earnings Details
4/29/2014Q114$0.25$0.97$16.03 million$34.00 millionViewN/AView Earnings Details
2/26/2014Q413$0.42$0.44$21.91 million$21.30 millionViewListenView Earnings Details
10/31/2013Q313$0.14$0.33$16.96 million$17.80 millionViewListenView Earnings Details
7/31/2013Q2 2013$0.25$0.40$17.09 million$20.80 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Anika Therapeutics (NASDAQ:ANIK)
Current Year EPS Consensus Estimate: $1.96 EPS
Next Year EPS Consensus Estimate: $2.03 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162$0.19$0.25$0.22
Q2 20162$0.38$0.47$0.43
Q3 20162$0.46$0.47$0.47
Q4 20162$0.47$0.48$0.48
Q1 20171$0.48$0.48$0.48
Q2 20171$0.48$0.48$0.48
(Data provided by Zacks Investment Research)


Dividend History for Anika Therapeutics (NASDAQ:ANIK)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Anika Therapeutics (NASDAQ:ANIK)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/25/2016Raymond J LandDirectorSell2,695$43.62$117,555.90View SEC Filing  
2/27/2015Raymond J LandDirectorSell4,621$39.49$182,483.29View SEC Filing  
5/1/2014Charles H SherwoodCEOSell83,780$44.32$3,713,129.60View SEC Filing  
2/28/2014Charles H SherwoodCEOSell200,000$41.70$8,340,000.00View SEC Filing  
8/22/2013John C MoranDirectorSell5,000$24.35$121,750.00View SEC Filing  
8/8/2013Steve E WheelerDirectorSell26,984$23.61$637,092.24View SEC Filing  
8/7/2013Steve E WheelerDirectorSell11,016$27.01$297,542.16View SEC Filing  
8/6/2013Farmaceutici S.P.A. FidiaMajor ShareholderSell1,270,000$24.52$31,140,400.00View SEC Filing  
7/15/2013Charles H SherwoodCEOSell75,000$20.11$1,508,250.00View SEC Filing  
7/9/2013Charles H SherwoodCEOSell49,185$18.06$888,281.10View SEC Filing  
7/5/2013Charles H SherwoodCEOSell34,662$18.01$624,262.62View SEC Filing  
6/19/2013Charles H SherwoodCEOSell1,847$18.00$33,246.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Anika Therapeutics (NASDAQ:ANIK)
DateHeadline logoAnika Therapeutics Inc. (NASDAQ:ANIK) Reports Sales Of $26.581, Surprising Estimates By 7.789% - Investor Newswire (NASDAQ:ANIK) - August 27 at 8:18 AM logoIllumina Keen on Genome Network Growth & Global Expansion (NASDAQ:ANIK) - August 26 at 3:28 PM logoAdhesion Barrier Market by Product, Product Form, Application - Global Forecast to 2021 (NASDAQ:ANIK) - August 25 at 8:54 PM
News IconResearch details developments in the adhesion barriers market that will be worth 1,216.8 million USD by 2021 (NASDAQ:ANIK) - August 25 at 8:54 PM logoAnika Therapeutics : to Participate in Upcoming Investor Conferences (NASDAQ:ANIK) - August 25 at 8:54 PM logoAnika to Participate in Upcoming Investor Conferences (NASDAQ:ANIK) - August 25 at 8:54 PM
News IconMarket Intelligence Report Hyaluronic Acid Products, 2015-2025 (NASDAQ:ANIK) - August 25 at 3:32 PM
News IconHyaluronic Acid Market Size To Reach $13.4 Billion By 2024: Grand View Research, Inc. (NASDAQ:ANIK) - August 25 at 3:32 PM
News IconStock Heading Down Over the Last Month Anika Therapeutics Inc. (NASDAQ:ANIK) - Post News (NASDAQ:ANIK) - August 25 at 8:18 AM
News IconAdhesion barriers market worth 1,216.8 million USD by 2021 according to new research report (NASDAQ:ANIK) - August 24 at 11:46 AM logoAnika Therapeutics Inc. (NASDAQ:ANIK) Gets 0 Recommendations To Sell - Investor Newswire (NASDAQ:ANIK) - August 23 at 7:47 AM logoXenetic's IND to Start Phase II Virexxa Study Accepted in U.S. (NASDAQ:ANIK) - August 22 at 3:33 PM logoRegenerative Medicine Market Stood at US $2.6 Bn in 2012 and Predicted to Reach US $6.5 Bn by 2019 (NASDAQ:ANIK) - August 19 at 4:08 PM logoAnalysts See Sales Of $119.39 For Anika Therapeutics Inc. (NASDAQ:ANIK) - Investor Newswire (NASDAQ:ANIK) - August 19 at 11:55 AM
News IconRegenerative Medicine Market Stood at US$2.6 bn in 2012 and Predicted to Reach US$6.5 bn by 2019 (NASDAQ:ANIK) - August 18 at 11:54 AM logoEthical Issues and Post Implantation Rejections Dampen Growth of Global Regenerative Medicine Market (NASDAQ:ANIK) - August 17 at 3:33 PM logoWhy You Shouldn't Bet Against Anika Therapeutics (ANIK) Stock (NASDAQ:ANIK) - August 17 at 11:43 AM logoGlobal Hyaluronic Acid Market Report 2014-2020 - Research and Markets (NASDAQ:ANIK) - August 16 at 8:47 PM
News IconRegenerative Medicine Market Stood at a Valuation of US$2.6 Bn in 2012 and Projected to Be Worth US$6.5 Bn by 2019 (NASDAQ:ANIK) - August 16 at 8:47 PM logoWill Anika Therapeutics Inc. (NASDAQ:ANIK) Hit $60 Price Target? - Investor Newswire (NASDAQ:ANIK) - August 16 at 3:32 PM
News IconNon-Surgical Bio-Implants Market Value Share and Key Trends 2016-2026 (NASDAQ:ANIK) - August 13 at 3:30 PM
News IconRegenerative Medicine - Next Big Thing in Medical Science (NASDAQ:ANIK) - August 10 at 9:59 PM logoGlobal Medical Aesthetics Market Hits $69,786 Million Revenue by 2021 with Growing CAGR 5.5% (NASDAQ:ANIK) - August 9 at 4:36 PM logoRegenerative Medicine Industry in Asia Pacific to Show Highest Growth Rate (NASDAQ:ANIK) - August 9 at 12:16 PM
News IconGlobal Hyaluronic Acid Products Market is Expected to Reach USD 10,901.5 Mn by 2022 – Credence Research (NASDAQ:ANIK) - August 9 at 12:16 PM logoAllergan (AGN) Tops Q2 Earnings, Revises '16 Outlook (NASDAQ:ANIK) - August 8 at 3:32 PM logoANIKA THERAPEUTICS, INC. Financials (NASDAQ:ANIK) - August 6 at 3:38 PM logoETF’s with exposure to Anika Therapeutics, Inc. : August 5, 2016 (NASDAQ:ANIK) - August 5 at 3:32 PM logoANI Pharmaceuticals (ANIP) Catches Eye: Stock Jumps 6.9% (NASDAQ:ANIK) - August 5 at 11:55 AM logoArray BioPharma (ARRY) in Focus: Stock Moves 9.3% Higher (NASDAQ:ANIK) - August 5 at 11:55 AM logoAnika Therapeutics Inc. (ANIK) is Trading Lower on Unusual Volume for August 02 - (NASDAQ:ANIK) - August 4 at 3:35 PM logoAnika Therapeutics, Inc. :ANIK-US: Earnings Analysis: Q2, 2016 By the Numbers : August 4, 2016 (NASDAQ:ANIK) - August 4 at 12:01 PM logoAnika Therapeutics Inc. (ANIK) is Trading Higher on Unusual Volume for August 01 - (NASDAQ:ANIK) - August 3 at 3:34 PM logoRevenue Update on Anika Therapeutics Inc(NASDAQ:ANIK) - Trade Calls (NASDAQ:ANIK) - August 3 at 3:34 PM logoSeeing Serious Upside In Anika, Making Money On Europe's Pain (NASDAQ:ANIK) - August 3 at 3:34 PM logoFacial Rejuvenation Market Deep Research Report with Forecast (NASDAQ:ANIK) - August 3 at 12:03 PM logoANIKA THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report (NASDAQ:ANIK) - August 2 at 8:18 AM logoAnika Therapeutics Inc. (ANIK) is Trading Lower on Unusual Volume for July 28 - (NASDAQ:ANIK) - July 30 at 3:36 PM logoAnika Therapeutics Inc. (ANIK) Drops 6.39% on July 28 | - (NASDAQ:ANIK) - July 30 at 3:36 PM logoNew Broker Ratings For Anika Therapeutics Inc. (NASDAQ:ANIK ... - FTSE News (NASDAQ:ANIK) - July 29 at 3:31 PM
News IconLatest report: global non surgical bio implants market 2015 industry trends, demand, share, research, analysis 2022 (NASDAQ:ANIK) - July 28 at 10:11 PM logoAnika Therapeutics Inc.: Anika Reports Second Quarter 2016 Financial Results - The Wall Street Transcript (NASDAQ:ANIK) - July 28 at 12:12 PM logoAnika Therapeutics Inc Earnings Call scheduled for 9:00 am ET today (NASDAQ:ANIK) - July 28 at 9:00 AM logoEurope Viscosupplementation Market Will Reach at a CAGR of 5.1% from 2016 to 2026 (NASDAQ:ANIK) - July 27 at 9:16 PM logoGlobal Market for Regenerative Medicine & Stem Cells - What’s hot, what’s not, what’s next by 2019? (NASDAQ:ANIK) - July 27 at 9:16 PM
News IconAnika Reports Second Quarter 2016 Financial Results (NASDAQ:ANIK) - July 27 at 9:16 PM logoAnika Therapeutics : beats 2Q profit forecasts (NASDAQ:ANIK) - July 27 at 9:16 PM logoAnika beats 2Q profit forecasts (NASDAQ:ANIK) - July 27 at 5:59 PM logoCan Shares Of Anika Therapeutics Inc. (NASDAQ:ANIK) Hit $60? - Investor Newswire (NASDAQ:ANIK) - July 27 at 11:44 AM logoQ2 2016 Anika Therapeutics Inc Earnings Release - After Market Close (NASDAQ:ANIK) - July 27 at 7:07 AM


Anika Therapeutics (NASDAQ:ANIK) Chart for Saturday, August, 27, 2016

Last Updated on 8/27/2016 by Staff